Docoh
Loading...

34 results

Filter options loading...
Top filers
Top filing types
Recent filing years
DEF 14A
PCSA Processa Pharmaceuticals Inc
22 Apr 21
Definitive proxy
2:00pm
strategy. Director Independence The Nasdaq Marketplace Rules require a majority of a listed company’s Board of Directors to be comprised … , compensation and nominating and corporate governance committees be independent and that audit committee members also satisfy independence criteria set forth
10-K/A
2020 FY
PCSA Processa Pharmaceuticals Inc
7 Apr 21
Annual report (amended)
4:23pm
Board because of his extensive investment experience. Director Independence The Nasdaq Marketplace Rules require a majority of a listed company’s … also satisfy independence criteria set forth in Rule 10A-3 under the Exchange Act. Under Rule 5605(a)(2) of the Nasdaq Marketplace Rules, a director
8-K
EX-1.1
PCSA Processa Pharmaceuticals Inc
6 Oct 20
Processa Pharmaceuticals Announces Pricing of $19.2 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:05pm
of 2002 (the “Sarbanes-Oxley Act”)) and (z) not in violation of the auditor independence requirements of the Sarbanes-Oxley Act. (vii) Organization
424B4
PCSA Processa Pharmaceuticals Inc
5 Oct 20
Prospectus supplement with pricing info
4:16pm
, resignation or removal. Director Independence The Nasdaq Marketplace Rules require a majority of a listed company’s Board of Directors to be comprised … satisfy independence criteria set forth in Rule 10A-3 under the Exchange Act. Under Rule 5605(a)(2) of the Nasdaq Marketplace Rules, a director will only
S-1/A
PCSA Processa Pharmaceuticals Inc
30 Sep 20
IPO registration (amended)
4:06pm
their successors have been elected and qualified or until the earlier of their death, resignation or removal. Director Independence The Nasdaq Marketplace Rules … governance committees be independent and that audit committee members also satisfy independence criteria set forth in Rule 10A-3 under the Exchange
S-1/A
jbifn4xjk4pjqjrebov1
16 Sep 20
IPO registration (amended)
8:00pm
S-1/A
EX-1.1
7steweec21z mdg8
16 Sep 20
IPO registration (amended)
8:00pm
S-1/A
EX-3.2
am4s2kftu
16 Sep 20
IPO registration (amended)
8:00pm
S-1/A
jfeq w7tf
17 Jul 20
IPO registration (amended)
5:25pm
10-K
erdlh
5 Mar 20
Annual report
7:00pm
S-1
039hb2q rdog
13 Dec 19
IPO registration
5:32pm
DEF 14A
vla ztaogpumi
26 Apr 19
Definitive proxy
5:02pm
424B3
268l5tn7 yh3vz26o
9 Nov 18
Prospectus supplement
5:04pm
S-1/A
8hqi9 xiab8qq7
30 Oct 18
IPO registration (amended)
4:19pm
S-1/A
5dfqcf 3rfa
9 Oct 18
IPO registration (amended)
5:32pm
S-1/A
swfj 8lst4da
13 Sep 18
IPO registration (amended)
8:00pm
S-1
3ecyi4qs1hx r2
29 Jul 18
IPO registration
8:00pm
10-K/A
23pjwwa4
16 Apr 18
Annual report (amended)
8:00pm
10-K
3mwyotx8ri8a18p98
15 Apr 18
Annual report
8:00pm
8-K/A
tiz1f3g0qk7jqz
16 Oct 17
Entry into a Material Definitive Agreement
8:00pm